Multiple Sclerosis Risk Factors Contribute to Onset Heterogeneity
Overview
Authors
Affiliations
Background: The phenotypic presentation of multiple sclerosis (MS) may predict long-term outcomes and little is known about factors contributing to heterogeneity at MS onset. Given temporality, it is likely MS risk factors also influence presentation of the disease near onset.
Methods: Using a retrospective cross-sectional study of MS cases, we investigated: age of onset (AOO), number of impaired functional domains (NIFDs), time to second relapse (TT2R), and early relapse activity (ERA). Machine learning variable selection was applied to epidemiologic data for each outcome, followed by multivariable regression models. The models were further adjusted for HLA-DRB1*15:01 carrier status and a MS genetic risk score (GRS). The TT2R and ERA analyses were restricted to relapsing remitting MS cases.
Results: HLA-DRB1*15:01, GRS, and smoking were associated with earlier AOO. Cases who were male, obese, had lower education, or had primary progressive MS were older at onset. For NIFDs, those with relapsing remitting MS and of lower SES had increased NIFDs. Among relapsing remitting cases, those who were older at onset, obese, and had polyfocal presentation had shorter TT2R, while ERA was greater among those younger at onset and who were obese.
Conclusion: Individual characteristics including age, genetic profiles, obesity, and smoking status contribute to heterogeneity in disease presentation and modulate early disease course evolution.
Leptin and Leptin Signaling in Multiple Sclerosis: A Narrative Review.
Flores-Cordero J, Aranaz-Murillo A, Vilarino-Garcia T, Perez-Perez A, Izquierdo G, Flores-Campos R Neuromolecular Med. 2025; 27(1):19.
PMID: 40019662 PMC: 11870953. DOI: 10.1007/s12017-025-08842-4.
Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis.
Sanabria-Diaz G, Cagol A, Lu P, Barakovic M, Ocampo-Pineda M, Chen X Ann Neurol. 2024; .
PMID: 39390658 PMC: 11683175. DOI: 10.1002/ana.27102.
Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.
Campanioni S, Veiga C, Prieto-Gonzalez J, Gonzalez-Novoa J, Busto L, Martinez C PLoS One. 2024; 19(7):e0306999.
PMID: 39012871 PMC: 11251627. DOI: 10.1371/journal.pone.0306999.
Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.
Misicka E, Huang Y, Loomis S, Sadhu N, Fisher E, Gafson A Neurol Genet. 2024; 10(3):e200159.
PMID: 38817245 PMC: 11139017. DOI: 10.1212/NXG.0000000000200159.
Papetti L, Panella E, Monte G, Ferilli M, Tarantino S, Proietti Checchi M Nutrients. 2023; 15(23).
PMID: 38068737 PMC: 10707944. DOI: 10.3390/nu15234880.